Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Times Interest Earned (2010 - 2026)

Incyte's (INCY) quarterly Times Interest Earned came in at $110.78 in Q2 2026, up 19.07% YoY from $93.04 in Q2 2025, and up 135.45% on a QoQ basis from $47.05 in Q1 2026.

Analysis

Incyte (INCY) Times Interest Earned (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Times Interest Earned data on file, last reported at $110.78 in Q2 2026.

  • Quarterly Times Interest Earned rose 19.07% year-over-year to $110.78 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1125.6 (down 2145.48% YoY) and the FY2025 annual result came in at $67.63, up 235699.99% from the prior year.
  • Times Interest Earned rose to $110.78 in Q2 2026, from $47.05 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $749.19 in Q3 2025 to a low of -$91.95 in Q2 2024.
  • A 5-year average of $73.29 and a median of $39.16 in 2023 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2024 — Times Interest Earned slumped 289.8% — and 2025, when it surged 2566.78%.
  • Tracing INCY's Times Interest Earned over 5 years: stood at $105.09 in 2022, then slumped by 114.79% to -$15.54 in 2023, then surged by 504.15% to $62.82 in 2024, then sank by 135.95% to -$22.58 in 2025, then jumped by 590.53% to $110.78 in 2026.
  • The last three Times Interest Earned figures came in at $110.78 (Q2 2026), $47.05 (Q1 2026), and -$22.58 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 1,199.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,199.14
Mar 31, 2026 529.20
Dec 31, 2025 577.08
Sep 30, 2025 749.19
Jun 30, 2025 892.78
Mar 31, 2025 310.86
Dec 31, 2024 719.60
Sep 30, 2024 188.74
Jun 30, 2024 -727.75
Mar 31, 2024 213.72
Dec 31, 2023 232.92
Sep 30, 2023 344.63
Jun 30, 2023 295.85
Mar 31, 2023 52.81
Dec 31, 2022 105.09
Sep 30, 2022 215.88
Jun 30, 2022 375.27
Mar 31, 2022 171.38
Dec 31, 2021 147.25
Sep 30, 2021 536.24